Kidney TransplantationKidney Failure, ChronicGraft RejectionGraft SurvivalKidneyImmunosuppressive AgentsTissue DonorsTransplantsTransplantation, HomologousTransplantationTacrolimusKidney DiseasesLiving DonorsCyclosporineTissue and Organ ProcurementMycophenolic AcidWaiting ListsCadaverHeart TransplantationImmunosuppressionTime FactorsTreatment OutcomeBK VirusRetrospective StudiesDelayed Graft FunctionPostoperative ComplicationsLung TransplantationPolyomavirus InfectionsHistocompatibility TestingPancreas TransplantationCreatinineKidney Function TestsRisk FactorsGlomerular Filtration RateIsoantibodiesCytomegalovirus InfectionsDirected Tissue DonationAntilymphocyte SerumKidney TubulesFollow-Up StudiesBone Marrow TransplantationBiopsyImmunocompromised HostRenal DialysisTransplantation ImmunologyHLA AntigensAcute Kidney InjuryPrimary Graft DysfunctionProspective StudiesHematopoietic Stem Cell TransplantationHistocompatibilitySurvival RateSirolimusCalcineurinIranComplement C4bIncidenceFetal Tissue TransplantationRenal InsufficiencyKidney CortexDonor SelectionSurvival AnalysisProportional Hazards ModelsDrug Therapy, CombinationCohort StudiesBrain DeathCytomegalovirusBiological MarkersKidney GlomerulusDrug MonitoringGingival HypertrophyTransplantation ToleranceKaplan-Meier EstimateNephrectomyKidney NeoplasmsLiver FailureRisk AssessmentPrognosisGanciclovirAcute DiseaseRegistriesRecurrenceBlood Group IncompatibilityGraft vs Host DiseaseUreteral DiseasesPostoperative PeriodKidney Tubular Necrosis, AcuteMultivariate AnalysisLymphoproliferative DisordersAzathioprineHeart-Lung TransplantationUnited StatesChronic DiseasePolycystic Kidney DiseasesTransplantation, AutologousPlasmapheresisProteinuriaBrain Tissue TransplantationFatal OutcomeDeath